LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

3.5 -0.28

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.4

Max

3.57

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
EPS	-0.712
Gewinnspanne	-77.289
Angestellte	260
EBITDA	4M -8.1M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+84.14% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-16M 105M
Vorheriger Eröffnungskurs	3.78
Vorheriger Schlusskurs	3.5

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Dez. 2025, 23:58 UTC

Akquisitionen, Fusionen, Übernahmen

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

11. Dez. 2025, 23:56 UTC

Ergebnisse

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

11. Dez. 2025, 23:03 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

11. Dez. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

11. Dez. 2025, 21:50 UTC

Ergebnisse

Costco Same-Store Sales, Membership Fees Rose in 1Q

11. Dez. 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Dez. 2025, 23:44 UTC

Market Talk

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

11. Dez. 2025, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

11. Dez. 2025, 23:31 UTC

Ergebnisse

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11. Dez. 2025, 22:48 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

11. Dez. 2025, 22:35 UTC

Ergebnisse

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

11. Dez. 2025, 22:30 UTC

Ergebnisse

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

11. Dez. 2025, 22:09 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

11. Dez. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

11. Dez. 2025, 22:05 UTC

Ergebnisse

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

11. Dez. 2025, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

11. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

11. Dez. 2025, 21:39 UTC

Ergebnisse

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

11. Dez. 2025, 21:39 UTC

Ergebnisse

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

11. Dez. 2025, 21:38 UTC

Ergebnisse

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

11. Dez. 2025, 21:37 UTC

Ergebnisse

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

11. Dez. 2025, 21:37 UTC

Market Talk

Broadcom Sees AI Revenue Doubling -- Market Talk

11. Dez. 2025, 21:34 UTC

Akquisitionen, Fusionen, Übernahmen

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

11. Dez. 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

Dexus Aiming for Long-Term Holding of A$50M in Fund

11. Dez. 2025, 21:28 UTC

Market Talk

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

11. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Dexus Expects to Introduce Additional Third-Party Equity in FY26

11. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Dexus: Third Party Investors to Contribute Remainder

11. Dez. 2025, 21:27 UTC

Akquisitionen, Fusionen, Übernahmen

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

11. Dez. 2025, 21:26 UTC

Akquisitionen, Fusionen, Übernahmen

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

11. Dez. 2025, 21:25 UTC

Akquisitionen, Fusionen, Übernahmen

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

84.14% Vorteil

12-Monats-Prognose

Durchschnitt 6.5 USD 84.14%

Hoch 11 USD

Tief 3 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.